BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35632711)

  • 1. Use of Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy in People Living with HIV.
    Pinnetti C; Cimini E; Vergori A; Mazzotta V; Grassi G; Mondi A; Forbici F; Amendola A; Grisetti S; Baldini F; Candela C; Casetti R; Campioni P; Capobianchi MR; Agrati C; Antinori A
    Viruses; 2022 May; 14(5):. PubMed ID: 35632711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy.
    Gasnault J; Costagliola D; Hendel-Chavez H; Dulioust A; Pakianather S; Mazet AA; de Goer de Herve MG; Lancar R; Lascaux AS; Porte L; Delfraissy JF; Taoufik Y;
    PLoS One; 2011; 6(6):e20967. PubMed ID: 21738597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
    Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
    N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and Prognostic Value of JC Virus DNA in Plasma in Progressive Multifocal Leukoencephalopathy.
    Ferretti F; Bestetti A; Yiannoutsos CT; Musick BS; Gerevini S; Passeri L; Bossolasco S; Boschini A; Franciotta D; Lazzarin A; Cinque P
    Clin Infect Dis; 2018 Jun; 67(1):65-72. PubMed ID: 29346632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region.
    Mubanga E; Patel A; Siddiqi OK; Hanson BA; Dang X; Lakhi S; Mulundu G; Bender N; Koralnik IJ
    J Neurovirol; 2019 Aug; 25(4):475-479. PubMed ID: 31028690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
    Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy.
    Koralnik IJ; Boden D; Mai VX; Lord CI; Letvin NL
    Neurology; 1999 Jan; 52(2):253-60. PubMed ID: 9932940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.
    Iannetta M; Bellizzi A; Lo Menzo S; Anzivino E; D'Abramo A; Oliva A; D'Agostino C; d'Ettorre G; Pietropaolo V; Vullo V; Ciardi MR
    J Neurovirol; 2013 Jun; 19(3):274-9. PubMed ID: 23715894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy.
    Delbue S; Elia F; Carloni C; Tavazzi E; Marchioni E; Carluccio S; Signorini L; Novati S; Maserati R; Ferrante P
    J Cell Physiol; 2012 Oct; 227(10):3511-7. PubMed ID: 22253012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does anti-JCV therapy improve the prognosis of AIDS-related PML?
    Mikita K; Maeda T; Fujikura Y; Kozaki Y; Hara Y; Kanoh S; Kishida S; Saijo M; Nakamichi K; Kawana A
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1853-4. PubMed ID: 23481900
    [No Abstract]   [Full Text] [Related]  

  • 11. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response.
    Giudici B; Vaz B; Bossolasco S; Casari S; Brambilla AM; Lüke W; Lazzarin A; Weber T; Cinque P
    Clin Infect Dis; 2000 Jan; 30(1):95-9. PubMed ID: 10619739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab.
    Varmpompiti K; Westwood AJ; Ben-Joseph A; Sibtain N; Ibrahim MAA; Stanton B; Zuckerman M; Hadden R; Ritter LM
    J Neuroimmunol; 2023 Dec; 385():578248. PubMed ID: 37995595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy.
    Gasnault J; Kahraman M; de Goër de Herve MG; Durali D; Delfraissy JF; Taoufik Y
    AIDS; 2003 Jul; 17(10):1443-9. PubMed ID: 12824781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-infected patients with or without progressive multifocal leukoencephalopathy.
    Andréoletti L; Lescieux A; Lambert V; Si-Mohamed A; Matta M; Wattré P; Bélec L
    J Med Virol; 2002 Jan; 66(1):1-7. PubMed ID: 11748651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JCV detection in multiple sclerosis patients treated with natalizumab.
    Sadiq SA; Puccio LM; Brydon EW
    J Neurol; 2010 Jun; 257(6):954-8. PubMed ID: 20052484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy.
    Lednicky JA; Vilchez RA; Keitel WA; Visnegarwala F; White ZS; Kozinetz CA; Lewis DE; Butel JS
    AIDS; 2003 Apr; 17(6):801-7. PubMed ID: 12660526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy?
    Mornese Pinna S; Scarvaglieri E; Milia MG; Imperiale D; Ghisetti V; Audagnotto S; Prochet A; Lipani F; Bonora S; Di Perri G; Calcagno A
    J Neurovirol; 2017 Oct; 23(5):763-767. PubMed ID: 28681343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.
    Lima MA; Marzocchetti A; Autissier P; Tompkins T; Chen Y; Gordon J; Clifford DB; Gandhi RT; Venna N; Berger JR; Koralnik IJ
    J Virol; 2007 Apr; 81(7):3361-8. PubMed ID: 17229701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of PCR as a tool for detection of JC virus DNA in cerebrospinal fluid for diagnosis of progressive multifocal leukoencephalopathy.
    Hammarin AL; Bogdanovic G; Svedhem V; Pirskanen R; Morfeldt L; Grandien M
    J Clin Microbiol; 1996 Dec; 34(12):2929-32. PubMed ID: 8940424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression increases JC polyomavirus large T antigen DNA load in the brains of patients without progressive multifocal leukoencephalopathy.
    Bayliss J; Karasoulos T; McLean CA
    J Infect Dis; 2013 Jan; 207(1):133-6. PubMed ID: 23112281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.